New Coronavirus Vaccine Candidate Shows Promise In Early, Limited Trial

Cambridge, Mass.-based Moderna, Inc., is reporting preliminary data suggesting its COVID-19 vaccine is safe, and appears to be triggering an immune response in test subjects.